IDEXX Laboratories Inc (XTER:IX1)
€ 417.5 0.9 (0.22%) Market Cap: 34.07 Bil Enterprise Value: 34.69 Bil PE Ratio: 44.50 PB Ratio: 23.46 GF Score: 99/100

IDEXX Laboratories Inc Investor Day (overall companion) Transcript

Aug 14, 2019 / 07:00PM GMT
Jay Mazelsky
IDEXX Laboratories, Inc. - Interim President & CEO

Good afternoon. Welcome to IDEXX Laboratories 2019 Investor Day scheduled for today and tomorrow. I'm Jay Mazelsky, the Interim CEO of IDEXX, and I'd like to welcome everybody who's physically come here to Maine as well as those virtually joining us through the webcast, also available for both days. Today, we're scheduled to go to approximately 4:45, and we'll restart tomorrow at 8 a.m. sharp.

Before we begin, we want to thank everybody for their best wishes related to Jon Ayers' recovery, which he greatly appreciates and sends his regards. We don't have additional updates to share at this time beyond what we shared in Jon's statement of July 24. I'm in touch with Jon, and he's in great spirits. He's fully engaged with his rehabilitation and has expressed great confidence in the leadership of the team who'll be presenting the strategy today and tomorrow.

I'd like to also mention that we have members of our management team in the audience and that you'll have a chance to speak to them throughout the event. So let me get

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot